AONC (American Oncology Network) ROCE %: 6.99% (As of Dec. 2024)


AONC American Oncology Network Inc AONC
20 GF Score
Price $10.00
View Full Analysis

What is American Oncology Network ROCE %?

American Oncology Network AONC 20 ROCE % is 6.99% as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. American Oncology Network's annualized ROCE % for the quarter that ended in Dec. 2024 was 6.99%.


American Oncology Network  (OTCPK:AONC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


American Oncology Network ROCE % Related Terms


American Oncology Network ROCE % Historical Data

* Premium members only.

The historical data trend for American Oncology Network's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network ROCE % Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
0.00 1.38 3.82 -28.71 -7.65

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -37.74 -41.38 -2.97 0.64 6.99
AONC
20GF Score
American Oncology Network Inc AONC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network ROCE % Calculation

American Oncology Network's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-17.556/( ( (374.453 - 169.045) + (470.328 - 216.847) )/ 2 )
=-17.556/( (205.408+253.481)/ 2 )
=-17.556/229.4445
=-7.65 %

American Oncology Network's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=15.68/( ( (394.811 - 199.857) + (470.328 - 216.847) )/ 2 )
=15.68/( ( 194.954 + 253.481 )/ 2 )
=15.68/224.2175
=6.99 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.99% mean?
American Oncology Network (AONC) has a ROCE % of 6.99% as of Dec. 2024.
Is American Oncology Network's ROCE % too high?
American Oncology Network's current ROCE % is 6.99%. The Healthcare Providers & Services industry median ROCE % is 6.41. American Oncology Network's value of 6.99% is 9% above this industry median. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's ROCE % compare to TOI and AUNA?
American Oncology Network's ROCE % of 6.99% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. American Oncology Network's value of 6.99% is 9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Oncology Network's current ROCE % of 6.99% is 9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Oncology Network's current ROCE % is 6.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current ROCE % of 6.99%. The current ROCE % is 6.99% and 9% above the Healthcare Providers & Services industry median of 6.41. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For American Oncology Network (AONC), the current ROCE % is 6.99% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price